Apobec-1 and apolipoprotein B mRNA editing
- PMID: 9084497
- DOI: 10.1016/s0005-2760(96)00156-7
Apobec-1 and apolipoprotein B mRNA editing
Abstract
Apolipoprotein (apo)B mRNA editing is a novel mechanism for the post-transcriptional regulation of gene expression in mammals. It consists of a C-->U conversion of the first base of the codon CAA, encoding glutamine-2153, to UAA, an in-frame stop codon, in apoB mRNA. Since its initial description in 1987, substantial progress has been made in the last few years on the mechanism of editing. Apobec-1, the catalytic component of the apoB mRNA editing enzyme complex, has been cloned. This article begins with an overview of the general biology of apoB mRNA editing. It then provides an in-depth analysis of the structure, evolution and possible mechanism of action of apobec-1. ApoB mRNA editing is the prototype of RNA editing in mammals. What we learn from apoB mRNA editing will be useful in our understanding of other examples of RNA editing in vertebrates which are being described with increasing frequency.
Similar articles
-
Apolipoprotein B messenger RNA editing: an update.Biochimie. 1995;77(1-2):75-8. doi: 10.1016/0300-9084(96)88107-7. Biochimie. 1995. PMID: 7599279 Review.
-
Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits.Hum Gene Ther. 1996 Jan;7(1):39-49. doi: 10.1089/hum.1996.7.1-39. Hum Gene Ther. 1996. PMID: 8825867
-
RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA.Biochim Biophys Acta. 2000 Nov 15;1494(1-2):1-13. doi: 10.1016/s0167-4781(00)00219-0. Biochim Biophys Acta. 2000. PMID: 11072063 Review.
-
Apolipoprotein B mRNA editing: a key controlling element targeting fats to proper tissue.Ann Med. 1993 Dec;25(6):539-43. Ann Med. 1993. PMID: 8292303 Review.
-
C-->U editing of apolipoprotein B mRNA in marsupials: identification and characterisation of APOBEC-1 from the American opossum Monodelphus domestica.Nucleic Acids Res. 1999 Jul 1;27(13):2662-71. doi: 10.1093/nar/27.13.2662. Nucleic Acids Res. 1999. PMID: 10373583 Free PMC article.
Cited by
-
Apo E structure determines VLDL clearance and atherosclerosis risk in mice.J Clin Invest. 1999 Jun;103(11):1579-86. doi: 10.1172/JCI6172. J Clin Invest. 1999. PMID: 10359567 Free PMC article.
-
Impact of APOBEC3s on the occurrence, development and prognosis of esophageal squamous cell carcinoma.Future Oncol. 2025 Jan;21(1):117-125. doi: 10.1080/14796694.2024.2442300. Epub 2024 Dec 30. Future Oncol. 2025. PMID: 39840662 Free PMC article. Review.
-
Transglycosylation: a mechanism for RNA modification (and editing?).Bioorg Chem. 2005 Jun;33(3):229-51. doi: 10.1016/j.bioorg.2005.01.001. Epub 2005 Feb 23. Bioorg Chem. 2005. PMID: 15888313 Free PMC article. Review.
-
Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion.Lipids. 2003 Jan;38(1):53-63. doi: 10.1007/s11745-003-1031-y. Lipids. 2003. PMID: 12669820
-
Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.RNA. 2002 Jan;8(1):69-82. doi: 10.1017/s1355838202015649. RNA. 2002. PMID: 11871661 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous